Huntington’s disease poses a threat to the brain—the core governing system of sensation, intellectual ability, nerve-related ...

After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...

Huntington's Disease is one of the most devastating diseases out there and many people have never heard of it. Actor WIll ...

Sage Therapeutics discontinued development of its lead candidate dalzanemdor after a third clinical failure, leading analysts ...

Huntington's Disease is one of the most devastating diseases out there and many people have never heard of it. Actor WIll ...

The genetic mutation that causes Huntington's disease may also enhance early brain development and promote intelligence.

After previously failing studies in Parkinson’s and Alzheimer’s, dalzanemdor’s latest stumble in Huntington’s disease has ...

Scientists at La Trobe University have created a world-first method to investigate "disordered" proteins in living cells, in ...

Alzheimer’s and Huntington’s patients do have different symptoms and disease biology, but that made no difference to the ...

Sage Therapeutics' run of bad news has continued with a failed phase 2 trial of dalzanemdor as a treatment for cognitive ...

PTC Therapeutics halts Utreloxastat development after ALS trial disappoints. Analysts highlight promising pipeline, including ...

It was the third failed trial for the therapy, called dalzanemdor, which also failed to meet its goals in a Phase 2 trial as ...